Evidence map›Paper›PMID 19284588›Full record

ArticleJournal of neuroinflammation2009

Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain.

Eléonore Beurel, Richard S Jope

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 235 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Interleukin-6, CD8Frontiers in aging neuroscience · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Immunomodulatory Potential of Kaempferol Isolated fromInternational journal of molecular sciences · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eléonore BeurelDepartment of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA. eleonore_beurel@hotmail.fr
Richard S Jope
University of Alabama at Birmingham · US

Funding

LITHIUM EFFECTS ON CHOLINERGIC ACTIVITYR01MH038752 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI JOPE, RICHARD S. · 1985 to 2015
$4.4M
NEURONAL SIGNALING--OXIDANTS AND ALZHEIMERS DISEASER01NS037768 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JOPE, RICHARD S · 1999 to 2007
$1.8M
Effects of lithium on cellular signalingR56MH038752 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JOPE, RICHARD S. · 2011 to 2011
$366k
NIMH NIH HHS MH38752NIMH NIH HHS R01 MH038752NIMH NIH HHS R56 MH038752NINDS NIH HHS NS37768NINDS NIH HHS R01 NS037768
6 · The paper itself

Abstract

backgroundSeptic shock is a prevalent condition that, when not lethal, often causes disturbances in cognition, mood, and behavior, particularly due to central actions of the inflammatory cytokine interleukin-6 (IL-6). To identify potential targets to control brain IL-6, we tested if IL-6 produced by glia is regulated by signal transducer and activator of transcription-3 (STAT3) and glycogen synthase kinase-3 (GSK3).

methodsLipopolysaccharide (LPS) was used to induce inflammatory responses in mice or cultured primary glia. IL-6 was measured by ELISA and other inflammatory molecules were measured using an array.

resultsMouse brain IL-6 levels increased after central, as well as peripheral, LPS administration, consistent with glia producing a portion of brain IL-6. STAT3 in the brain was activated after peripheral or central LPS administration, and in LPS-stimulated cultured primary glia. Inhibition of STAT3 expression, function, or activation reduced by ~80% IL-6 production by primary glia, demonstrating the dependence on active STAT3. GSK3 promotes STAT3 activation, and array analysis of inflammatory molecules produced by LPS-stimulated primary glia demonstrated that IL-6 was the cytokine most diminished (>90%) by GSK3 inhibition. Inhibition of GSK3, and knockdown of GSK3beta, not GSK3alpha, greatly inhibited IL-6 production by LPS-stimulated primary glia. Conversely, expression of active STAT3 and active GSK3 promoted IL-6 production. In vivo inhibition of GSK3 reduced serum and brain IL-6 levels, brain STAT3 activation, and GFAP upregulation following LPS administration.

conclusionSTAT3 and GSK3 cooperatively promote neuroinflammation, providing novel targets for anti-inflammatory intervention.

Indexed as

AnimalsBrainCells, CulturedCytokinesEscherichia coliGene Knockdown TechniquesGlial Fibrillary Acidic ProteinGlycogen Synthase Kinase 3InflammationInterleukin-6LipopolysaccharidesLithium CompoundsMaleMiceMice, Inbred C57BLNeurogliaCytokinesGlial Fibrillary Acidic ProteinGlycogen Synthase Kinase 3Interleukin-6LipopolysaccharidesLithium CompoundsStat3 protein, mouseSTAT3 Transcription Factor

Identifiers

PMID19284588
PMCPMC2660311
OpenAlexW2124851755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.